Signature Estate & Investment Advisors LLC grew its stake in shares of Amdocs Limited (NASDAQ:DOX – Get Rating) by 1.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 27,933 shares of the technology company’s stock after acquiring an additional 327 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in Amdocs were worth $2,540,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Private Trust Co. NA bought a new stake in Amdocs during the 2nd quarter worth $36,000. Ellevest Inc. grew its holdings in shares of Amdocs by 1,015.4% during the third quarter. Ellevest Inc. now owns 580 shares of the technology company’s stock worth $46,000 after purchasing an additional 528 shares during the last quarter. Exchange Traded Concepts LLC bought a new stake in shares of Amdocs during the third quarter worth about $49,000. Riverview Trust Co raised its holdings in Amdocs by 32.8% in the 3rd quarter. Riverview Trust Co now owns 611 shares of the technology company’s stock valued at $49,000 after buying an additional 151 shares during the last quarter. Finally, Ronald Blue Trust Inc. boosted its position in Amdocs by 262.7% during the 3rd quarter. Ronald Blue Trust Inc. now owns 845 shares of the technology company’s stock worth $70,000 after buying an additional 612 shares during the period. 88.11% of the stock is currently owned by institutional investors and hedge funds.
Amdocs Stock Down 0.4 %
Amdocs stock opened at $91.00 on Friday. The firm has a market cap of $10.99 billion, a price-to-earnings ratio of 20.50, a PEG ratio of 1.57 and a beta of 0.65. Amdocs Limited has a 52-week low of $76.79 and a 52-week high of $97.08. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 1.57. The firm has a 50 day moving average price of $92.24 and a two-hundred day moving average price of $87.34.
Amdocs Increases Dividend
Analyst Ratings Changes
Several equities analysts have issued reports on DOX shares. Oppenheimer upped their price target on shares of Amdocs from $94.00 to $99.00 and gave the company an “outperform” rating in a research report on Wednesday, February 1st. StockNews.com started coverage on Amdocs in a report on Thursday. They issued a “buy” rating for the company. Finally, Robert W. Baird lifted their target price on Amdocs from $85.00 to $100.00 and gave the stock a “neutral” rating in a report on Thursday, February 2nd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Amdocs has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.
Amdocs Ltd. is a holding company, which engages in the provision of software products and services for the communications, entertainment, and media industry service providers. The company was founded in 1988 and is headquartered in Saint Louis, MO.
- Get a free copy of the StockNews.com research report on Amdocs (DOX)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Get Rating).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.